
Conference Coverage
Latest Content

Navigator Outreach Helped More Relatives of BRCA Carriers Get Tested

FDA Approves Jaypirca as First-Line Treatment for CLL and SLL

Giredestrant Combo Cuts Progression Risk by 44% in Advanced Breast Cancer

Shorter Radiation After Prostate Surgery Controlled Cancer as Well at 5 Years, With a Trade-Off

Why Staying on Hormone Therapy Matters When Skipping Radiation

Shorts










Videos
All News

September brought new options for breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus a brain tumor scan and easier lung cancer treatment.

Dr. Nitin Ohri explains how radiation treats cancer, how often treatment is needed, common side effects and how to tell if radiation is working.

Ivonescimab outperformed Keytruda, a new myeloma drug lowered progression risk by 60% and more: the biggest phase 3 cancer results of September 2026.

Breast cancer treatment has changed dramatically since 2021. Here are the key FDA approvals, year by year, and what they mean for patients.

Choosing hospice care brought comfort, support and precious time for one family as they navigated cancer, caregiving and bringing a loved one home.

Learn how to cope with life after cancer treatment with Dr. Eric Bengtsen, a psycho-oncology psychiatrist at Memorial Sloan Kettering Cancer Center.

Sue Weldon, a 22-year breast cancer survivor and Unite for HER founder, explains how integrative therapies helped her heal after chemotherapy.

On National Previvor Day, learn what it means to carry an inherited gene change like BRCA1 or BRCA2, and the screening and surgery options that lower risk.

Patients with HPV-associated oropharyngeal cancer who received 23% less radiation reported fewer swallowing, voice and dry mouth problems six months after treatment.

Heather Curley discusses her leptomeningeal disease diagnosis, joining an experimental vaccine trial and the milestones she has been able to share with her daughter.

A phase 3 trial presented at ASTRO 2026 found that giving focused radiation in three to five sessions, instead of one, lowered the chance of cancer returning at the surgery site, and patients lived longer.

A new radiation implant placed during surgery for brain metastases nearly stopped tumors from returning and doubled survival, a new study found.

Six years after being diagnosed with B-cell ALL at 21, William Yank opens up about the physical changes of treatment, the emotional weight of constant care and the role hope plays in his survivorship.

Long-term results presented at ASTRO 2026 show that a shorter radiation schedule after mastectomy controls high-risk breast cancer as well as the standard five-week course, without more long-term side effects.

FDA fast-tracks review of elinzanetant for hot flashes linked to breast cancer treatment. Here’s what the trial found and what patients should know.






























